Au JS - Search Results

1

miR-145 as a Potential Biomarker and Therapeutic Target in Patients with Non-Small Cell Lung Cancer.

Cho WC, Wong CF, Li KP, Fong AH, Fung KY, Au JS. Cho WC, et al. Among authors: au js. Int J Mol Sci. 2023 Jun 12;24(12):10022. doi: 10.3390/ijms241210022. Int J Mol Sci. 2023. PMID: 37373169 Free PMC article.

2

Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.

Cho WC, Chow AS, Au JS. Cho WC, et al. Among authors: au js. Eur J Cancer. 2009 Aug;45(12):2197-206. doi: 10.1016/j.ejca.2009.04.039. Epub 2009 Jun 1. Eur J Cancer. 2009. PMID: 19493678

3

MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1.

Cho WC, Chow AS, Au JS. Cho WC, et al. Among authors: au js. RNA Biol. 2011 Jan-Feb;8(1):125-31. doi: 10.4161/rna.8.1.14259. Epub 2011 Jan 1. RNA Biol. 2011. PMID: 21289483

4

Proteomic approach to biomarker discovery in cancer tissue from lung adenocarcinoma among nonsmoking Chinese women in Hong Kong.

Au JS, Cho WC, Yip TT, Law SC. Au JS, et al. Cancer Invest. 2008 Mar;26(2):128-35. doi: 10.1080/07357900701788031. Cancer Invest. 2008. PMID: 18259942

5

Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosis.

Cho WC, Yip TT, Cheng WW, Au JS. Cho WC, et al. Among authors: au js. Br J Cancer. 2010 Jun 8;102(12):1731-5. doi: 10.1038/sj.bjc.6605700. Epub 2010 May 25. Br J Cancer. 2010. PMID: 20502455 Free PMC article.

6

The role of inflammation in the pathogenesis of lung cancer.

Cho WC, Kwan CK, Yau S, So PP, Poon PC, Au JS. Cho WC, et al. Among authors: au js. Expert Opin Ther Targets. 2011 Sep;15(9):1127-37. doi: 10.1517/14728222.2011.599801. Epub 2011 Jul 13. Expert Opin Ther Targets. 2011. PMID: 21751938 Review.

7

MiR-30 Family Potentially Targeting PI3K-SIAH2 Predicted Interaction Network Represents a Novel Putative Theranostic Panel in Non-small Cell Lung Cancer.

Chan LW, Wang F, Meng F, Wang L, Wong SC, Au JS, Yang S, Cho WC. Chan LW, et al. Among authors: au js. Front Genet. 2017 Feb 2;8:8. doi: 10.3389/fgene.2017.00008. eCollection 2017. Front Genet. 2017. PMID: 28210267 Free PMC article.

8

Turning point for cancer management.

Cho WCS, Au JSK. Cho WCS, et al. Ann Transl Med. 2018 Jul;6(14):281. doi: 10.21037/atm.2018.06.41. Ann Transl Med. 2018. PMID: 30105231 Free PMC article. No abstract available.

9

Health economic analysis of epidermal growth factor receptor mutation-guided first-line therapies for advanced non-small-cell lung cancer: abridged secondary publication.

You JHS, Cho WCS, Li YC, Kwan CK, Au JSK. You JHS, et al. Hong Kong Med J. 2023 Feb;29 Suppl 2(1):8-11. Hong Kong Med J. 2023. PMID: 36950997 Free article. No abstract available.

10

Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling.

Cho WC, Yip TT, Yip C, Yip V, Thulasiraman V, Ngan RK, Yip TT, Lau WH, Au JS, Law SC, Cheng WW, Ma VW, Lim CK. Cho WC, et al. Among authors: au js. Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):43-52. doi: 10.1158/1078-0432.ccr-0413-3. Clin Cancer Res. 2004. PMID: 14734450 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

131 results

Search Page